News, stories and information from GE Healthcare on cancer-related topics such as cancer prevention, diagnosis and research.
Is My Cancer Different is an initiative dedicated to exploring how a simple question can make a huge difference in the fight against cancer.
From the minute a person is diagnosed with cancer they are faced with complicated terminology and difficult decisions. Asking some important, well-formed questions early in the decision-making process can help guide their personalized care.
Learn how individualized treatment is making a difference for patients with different types of cancer.
Breast Cancer Mosaic is a place where people meet and talk about their experience of increasing breast cancer awareness, and what happens when we reach out to those who are going through a difficult time.
By offering survivors, caregivers, doctors and families an opportunity to voice their unique, individual experiences, GE Healthcare hopes the Breast Cancer Mosaic will provide a way to help support those who may be coming into contact with breast cancer for the first time.
The Breast Cancer Mosaic also hosts BCMTalks, an initiative that seeks to actively engage those who desire to share their breast cancer experiences with their peers in the healthcare conversation online.
Give a Little Beat is a musical initiative and a first in the healthcare industry, connecting people in the fight against breast cancer through the power of music and social media.
Music can inspire, uplift and calm the spirits of those who need it most, and can be a great comfort during procedures and treatments. Music therapy is used by healthcare professionals to promote healing and enhance quality of life for their patients, to encourage emotional expression, promote social interaction, and relieve symptoms according to each patient's individual preferences.
Users can post their favorite tracks on the Jukebox as part of a collaboratively compiled playlist, or choose to listen to the beautiful and inspiring songs on the playlists that are already available.
In September 2011, GE Healthcare launched an ambitious global campaign against cancer, committing $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.
By the end of 2012, $335M had been invested, setting GE on track to meet its five-year commitment. To accelerate progress, and to deliver better care to 10 million patients by 2020, the campaign against cancer combines the strength of GE’s portfolio of cancer technologies with the innovations born from collaborations with key partners.
These commitments position GE to drive game-changing impact in oncology and a leap forward for individualized cancer care.